1 active not recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
Follow Ding Ma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia MTX 1, MTX 2, Act-d - Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia | Phase 3 | Unknown | Ding Ma | 300 | 2012-12-01 | 2019-12-24 |
| The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma Paclitaxel, Paraplatin (Carboplatin Injection), Pelvic Radiation - Endometrial Neoplasms | Phase 3 | Active not recruiting | Ding Ma | 300 | 2012-11-01 | 2024-04-02 |
Endometrial Neoplasms (1) · Gestational Trophoblastic Disease (1)
Carboplatin (1) · Dactinomycin (1) · Paclitaxel (1)
China (2)
Beihua Kong, MD, PhD (1) · Xing Xie, MD, PhD (1)